Clinuvel Pharmaceuticals Limited (OTCMKTS:CLVLY – Get Free Report)’s share price dropped 0.6% on Wednesday . The company traded as low as $7.52 and last traded at $7.77. Approximately 1,770 shares were traded during trading, a decline of 45% from the average daily volume of 3,218 shares. The stock had previously closed at $7.82.
Clinuvel Pharmaceuticals Trading Down 0.6%
The business has a fifty day simple moving average of $7.72 and a two-hundred day simple moving average of $7.25.
Clinuvel Pharmaceuticals Announces Dividend
The firm also recently disclosed a dividend, which will be paid on Monday, September 29th. Stockholders of record on Tuesday, September 9th will be issued a dividend of $0.0261 per share. This represents a dividend yield of 35.0%. The ex-dividend date is Monday, September 8th.
About Clinuvel Pharmaceuticals
Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally. Its lead drug candidate is SCENESSE, a systemic photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP).
Read More
- Five stocks we like better than Clinuvel Pharmaceuticals
- How is Compound Interest Calculated?
- Cybersecurity Market Set to Double: This ETF Offers Exposure
- What is the S&P/TSX Index?
- Downgraded But Not Done: 3 Stocks Ready for a Market Comeback
- What is the Dow Jones Industrial Average (DJIA)?
- Solana Beat BTC and ETH in Q3: These 3 Stocks Saw It Coming
Receive News & Ratings for Clinuvel Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clinuvel Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
